CMV VIREMIA
Clinical trials for CMV VIREMIA explained in plain language.
Never miss a new study
Get alerted when new CMV VIREMIA trials appear
Sign up with your email to follow new studies for CMV VIREMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart transplant trial tests safer infection prevention
Disease control Recruiting nowThis study aims to find the best drug to prevent a common and serious viral infection (CMV) in people who have received a heart transplant. It will compare the safety and effectiveness of a newer drug, letermovir, against the current standard, valganciclovir, in 150 adult transpl…
Matched conditions: CMV VIREMIA
Phase: PHASE2, PHASE3 • Sponsor: Columbia University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Virus-Fighting drug tested to halt breast Cancer's spread to the brain
Disease control Recruiting nowThis study is testing if adding an antiviral drug (valganciclovir) to standard care can help control breast cancer that has spread to the brain in patients who also have a common virus called CMV. It will enroll about 28 adults to see if the treatment shrinks tumors, improves sur…
Matched conditions: CMV VIREMIA
Phase: PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC